Oxford University Press, Metallomics, 2(11), p. 327-337, 2019
DOI: 10.1039/c8mt00285a
Full text: Unavailable
Mice treated daily with MT2 (but not MT1) showed a significant amelioration of the clinical course of experimental autoimmune encephalomyelitis (EAE).